Toggle Main Menu Toggle Search

Open Access padlockePrints

Subantimicrobial dose doxycycline enhances the efficacy of scaling and root planning in chronic periodontitis: A multicenter trial

Lookup NU author(s): Professor Philip Preshaw

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Abstract

Background: Previous studies have shown that subantimicrobial dose doxycycline (SDD) is of clinical benefit in the treatment of chronic periodontitis (CP). The aim of this study was to further assess the role of SDD as an adjunct to scaling and root planing (SRP) in the treatment of CP. Methods: A double-blind, randomized, placebo-controlled, multicenter clinical study was conducted to test the efficacy of SDD (20 mg doxycycline B.I.D.) in combination with SRP in subjects with moderate to severe CP. Two-hundred ten subjects were treated with a standardized episode of SRP and randomized to receive either adjunctive SDD or placebo for 9 months. Efficacy parameters included per-subject mean changes in clinical attachment level (CAL) and probing depth (PD) from baseline, and the total number of sites with attachment gains and probing depth reductions ≥2 mm and ≥3 mm from baseline. Results: In periodontal sites with PD 4 to 6 mm and ≥7 mm (N = 209, intent-to-treat population), mean improvements in CAL and PD were greater following SRP with adjunctive SDD than SRP with placebo, achieving statistical significance in all baseline disease categories at month 9 (P <0.05). At month 9, 42.3% of sites in the SDD group demonstrated CAL gain ≥2 mm compared to 32.0% of sites in the placebo group (P < 0.01). CAL gain ≥3 mm was seen in 15.4% of sites in the SDD group compared to 10.6% of sites in the placebo group (P <0.05). When considering the same thresholds of change in PD, 42.9% of sites in the SDD group compared to 31.1% of sites in the placebo group demonstrated PD reduction ≥2 mm (P <0.01), and 15.4% of sites in the SDD group compared to 9.1% of sites in the placebo group demonstrated PD reduction ≥3 mm (P <0.01). Conclusion: Adjunctive subantimicrobial dose doxycycline enhances scaling and root planing. It results in statistically significant attachment gains and probing depth reductions over and above those achieved by scaling and root planing with placebo.


Publication metadata

Author(s): Preshaw PM, Hefti AF, Novak MJ, Michalowicz BS, Pihlstrom BL, Schoor R, Trummel CL, Dean J, Van Dyke TE, Walker CB, Bradshaw MH

Publication type: Article

Publication status: Published

Journal: Journal of Periodontology

Year: 2004

Volume: 75

Issue: 8

Pages: 1068-1076

ISSN (print): 0022-3492

ISSN (electronic): 1943-3670

Publisher: American Academy of Periodontology

URL: http://dx.doi.org/10.1902/jop.2004.75.8.1068

DOI: 10.1902/jop.2004.75.8.1068

PubMed id: 15455733


Altmetrics

Altmetrics provided by Altmetric


Share